SPONSOR
First People's Hospital of Hangzhou
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 2, Phase 3
Conditions studied: Non-Small Cell Lung CancerHelicobacter Pylori InfectionClostridium Difficile Infection
First People's Hospital of Hangzhou is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Non-Small Cell Lung Cancer, Helicobacter Pylori Infection, Clostridium Difficile Infection.
The trial portfolio spans Phase 2, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — First People's Hospital of Hangzhou
How many clinical trials has First People's Hospital of Hangzhou sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by First People's Hospital of Hangzhou, of which 3 are actively recruiting participants. These trials cover conditions including Non-Small Cell Lung Cancer, Helicobacter Pylori Infection, Clostridium Difficile Infection. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does First People's Hospital of Hangzhou research focus on?
First People's Hospital of Hangzhou clinical trials span Non-Small Cell Lung Cancer, Helicobacter Pylori Infection, Clostridium Difficile Infection. The research pipeline includes Phase 2, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a First People's Hospital of Hangzhou clinical trial?
To participate in a First People's Hospital of Hangzhou trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all First People's Hospital of Hangzhou trials with current recruitment status updated daily.
Clinical Trials by First People's Hospital of Hangzhou
NCT06718309 Phase 2
Recruiting
Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC
Non-Small Cell Lung Cancer
NCT07242456 Phase 2, Phase 3
Recruiting
Head-to-head Study of Tegoprazan 50 mg BID Plus Amoxicillin 1 g TID vs. Vonoprazan 20 mg BID Plus Amoxicillin 1 g TID for H. Pylori Eradication
Helicobacter Pylori Infection
NCT06703918
Recruiting
Study on Clostridium Difficile Infection in Infants
Clostridium Difficile Infection
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology